A powerful new technology to identify HIV inhibitors
Providing long-term HIV treatment for over 33 million infected individuals worldwide requires the continuous development of new HIV therapies. Virologists at the Helmholtz Zentrum Munchen have developed a cell-based assay system for easy, reliable identification of HIV inhibitors. This new technology can be used to screen large collections of well-characterized reagents as well as raw extracts …
Published Dec 1, 2010.
Read more: PhysOrg